305 A high dose of inhaled budesonide is more cost-effective than a low dose in moderate asthma

Fredrik Andersson; Sixten Borg; Peter J Barnes; C.-G Lödfdahl; Paul M. O’Byrne; Dirkje Postma; Ruben Pauwels; A. E. Tattersfield; A. Ullman

doi:10.1016/s0091-6749(00)90734-6

Back

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article1997

A Comparison of Low-Dose Inhaled Budesonide plus Theophylline and High-Dose Inhaled Budesonide for Moderate Asthma

David J. Evans, David Taylor, Kian Fan Chung, Peter J Barnes

Article1998

A Comparison of Low-Dose Inhaled Budesonide Plus Theophylline and High-Dose Inhaled Budesonide for Moderate Asthma

David Evans, David A. Taylor, O. Zetterström, Kian Fan Chung, BRIAN J. O CONNOR, Peter J Barnes

Article2001

Low Dose Inhaled Budesonide and Formoterol in Mild Persistent Asthma

Paul M. O’Byrne, Peter J Barnes, Roberto Rodríguez-Roisin, E Runnerström, Thomas Sandström, Klas Svensson, Anne E. Tattersfield

Article2010

Fluticasone Furoate, A Novel Enhanced-affinity Inhaled Corticosteroid, Is More Potent Than Fluticasone Propionate And Budesonide In Human Respiratory Cell Lines

Kazuhiro Ito, Yasuo To, Christos Rossios, Peter J Barnes, Ian M. Adcock, Malcolm Johnson

Article2018

Inhaled Combined Budesonide–Formoterol as Needed in Mild Asthma

Paul M. O’Byrne, J. Mark FitzGerald, Eric D. Bateman, Peter J Barnes, Nanshan Zhong, Christina Keen, Carin Jorup, Rosa Lamarca, Stefan Ivanov, Helen K. Reddel